Sundar Shewale

YHOP was an incredible experience, broadening our perspectives and widening our horizons. Plus, we bagged 2nd place in the Quiz! 🙌 Big thanks to all our amazing teachers! #Grateful #Learning #YHOP @drsanjeev1980 @DrPMPGI @DrGPrakash @ASH_hematology

@DrGauravNarula @BloodPortfolio Congratulations...!!

OMG! We're a Plenary paper in #Blood @BloodPortfolio! Life Goals of 25 years ago achieved😀 (But as usual the goalpost shifted so another 25 on the horizon) This was great work & very happy to be a part of it A follow-up paper will shift the landscape in 2 yrs from now I think👍

CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia | New England Journal of Medicine nejm.org/doi/full/10.10…

Happy Ganesh chaturthi to all..!!!

Master myeloid maturation with this newer module I made!↘️↘️↘️↘️ classmarker.com/online-test/st… #HemePath #Hematology #pathology #PathTwitter

@drsanjeev1980 @ishbtHematology @IndMyAcGp @nihardesai7 @faheema_hasan Congratulations to Mam and SGPGI team....!;

What an amazing News, My Mentor, my ex HOD, currently Vice Chancellor of KGMU, Prof. Soniya Nityanand got the Padma Sri award ❤️❤️

@IELTS I have paid 17500 for registration. The transaction is successful but my registration is not successful....I got assurance that money will come back in 5 days. My query ticket no. is 362569. But nothing came back no money or your response.. Its consumer harassment....

What a year 2024 in hematology! Here's a thread on selected clinical studies we've seen this year🧵🩸

@GCC_Cortes @GACancerCenter @icmlf @BloodGlobalHema Merry Christmas Sir...!!! May God give you good health...

My run today. It is my way to wish everyone a very Merry Christmas. @GACancerCenter @icmlf @BloodGlobalHema

@GCC_Cortes @ASH_hematology @BloodGlobalHema @GACancerCenter Great..!!!

I first attended @ASH_hematology annual meeting in 1989. This is 35 consecutive years attending a great conference, with great science and meeting with friends. Now doing my part promoting Global Hematology with @BloodGlobalHema. @GACancerCenter #ASH24

@EshaKaul1 @purwarrahul2 @ActImmuno @hkJain_kmc Congratulations....Great....

CARs… Made in India…for the world ! ! #ASH24 …

@NicoGagelmann What do you feel.. will be safer compared to Cilta cel and Ide-cel..?

Phase 1 Results for BMS-986393 (GPRC5D CAR-T) in RRMM: -ORR: 87% overall (48% CR) -Durable responses in high-risk cytogenetics, extramedullary disease, prior BCMA therapy -Median PFS: 14.5 months -CRS 82% (mostly grade 1/2); ICANS (2% grade 3) -Less infection than BCMA CAR-T #ASH24 ash.confex.com/ash/2024/webpr…

CAR-T for multiple myeloma Short thread on selected abstracts at #ASH24 @ASH_hematology #mmsm

Understanding and treating myelofibrosis A short thread on selected clinical abstracts from #ASH24 @ASH_hematology #mpnsm

@nihardesai89 @ASH_hematology @Haemophage @NicoGagelmann @Kristin_Rathje @TheEBMT_Trainee @PanktiMehta24 @nihardesai7 Whats the role of this 2 Gy TBI ...?

The slide set is starting to take shape!! I am excited to present our data at #ASH24 💪🏼 Thank you @ASH_hematology for the opportunity and @Haemophage for the phenomenal mentorship 🙌🏼 See you all soon 😍 #MedTwitter

@AhmedKo45911157 How you treat asparaginase induced ICH..

Asparaginase in ALL Acute Lymphoblastic Leukemia ➡️Preparation ➡️Common side effects ➡️Reaction D.D ➡️Management of toxicity #SOHO2024

@JTHjournal Looks interesting..!

Acquired hemophilia is a rare, severe bleeding disorder that is difficult to treat. This review provides an algorithmic approach to treatment that includes emicizumab, limits hemostatic product use, and minimizes immunosuppression toxicity. #JTHinClinic #hemophilia jthjournal.org/article/S1538-…

@MeeraMohanMD @Transplant_Doc Thank you...

@Hemobuddy @Transplant_Doc These are complementary tests - MRI DWIBS can detect more bony focal lesions while PET CT is better at EMD

#ASH24 High total diffusion volume (tDV) by whole-body MRI correlates with shorter PFS, even in patients with MRD negative BM. -Combined BM MRD and WB MRI may optimize the response assessment #mmsm #bmtsm ash.confex.com/ash/2024/webpr…

@MeeraMohanMD @AjaiChari That's significant right..?

Delayed Neurotoxicity after CAR-T in Multiple Myeloma: Results from a Global IMWG Registry N=52 (92% cilta-cel 4% ide-cel) 16 PD & 37 CN palsies (4 cases of PN/GBS) 15% in </=1 LOT (7 CN and 1 PD) Is Neurotox really driven by disease burden ? @AjaiChari #mmsm #ASH2024

@Transplant_Doc @hcheruvalath @MeeraMohanMD Thanks Sir..how many doses..?

#ASH24 Effects of IVIG on Infections in Recipients of Teclistamab for MM. IVIG within the past 30 days may lower the risk of high-grade and bacterial infections #mmsm #bmtsm @hcheruvalath @MeeraMohanMD ash.confex.com/ash/2024/webpr…

@AhmedKo45911157 Well summarised..

Concise summary of FDA-approved #FollicularLymphoma treatments: ➡️ 1st line: BR ➡️ 2nd line: R-CHOP, R2, or ASCT (POD <24) ➡️ 3rd line: CAR-T (40m), Zanubrutinib/Obinutuzumab (28m), Mosunetuzumab (17.9m).